Study Compares Remote Electrical Neuromodulation to Migraine Meds in Adolescents
Nerivio is a wireless remote electrical neuromodulation device approved for the acute treatment of episodic or chronic migraine in patients 12 years of age and older.
Neurologic Disorders
Aduhelm Gets Accelerated Approval for Alzheimer Disease
The treatment, which is administered as a monthly intravenous infusion, binds to aggregated β-amyloid and promotes removal of amyloid from the brain.
Telehealth Use Up Markedly Among Patients With Parkinson Disease
A desire to continue using telehealth was associated with having received support/instruction and having a care partner to help.
Recognizing Signs and Symptoms of ADHD Across the Lifespan
Untreated ADHD in adults is associated with increased rates of unemployment and poor performance in educational and work settings.
Nerivio Device Cleared for Migraine in Adolescents
The approval was based on data from an open-label, single-arm study that evaluated the efficacy and safety of Nerivio in patients aged 12 to 17 years with migraine.
Neurologic Effects Seen in One-Third of Hospitalized COVID-19 Patients
Neurologic manifestations are common among hospitalized patients with COVID-19.
Atypical Sleep Tied to Language Skills in Neurodevelopmental Disorders
Nighttime sleep duration predicted receptive vocabulary size in Down syndrome, Williams syndrome.
- Loading...
Loading...
Next post in Sleep Information Center
Loading... 
Loading...